Smart Nanotechnology for Next-Generation Vaccine Development

The rising incidence of emerging and reemerging infectious diseases, together with the need for adaptable, rapid, and personalized vaccination platforms, has driven significant progress at the intersection of nanotechnology, synthetic biology, and artificial intelligence. Smart nanotechnology involves the use of a carefully designed nanoscale delivery system that allows for precise control of antigen delivery, immune system targeting, and helps overcome limitations associated with traditional vaccine methods. Coupled with AI-based tools for predicting epitopes, analyzing immune responses, and optimizing nanoparticle designs, these platforms promise to accelerate vaccine development, enabling personalized immunization (e.g., for cancer, rare infections, or rapidly evolving pathogens) and improving access to vaccines worldwide. This chapter provides an overview of how nanovaccines are designed, considering the type of nanomaterial, the mechanism of immune activation, and how AI is being integrated with nanomedicine. It introduces the main nanoparticle platforms (such as lipid, protein-based, polymeric, and virus-like particles), discusses their advantages and limitations, along with preclinical and clinical examples. Finally, it concludes by addressing future directions, including mucosal and needle-free delivery, multivalent/multiplex vaccines, self-amplifying RNA vaccines, theranostic “nanovaccines,” and AI-guided personalized immunization strategies.